For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220124:nRSX2829Za&default-theme=true
RNS Number : 2829Z Eco Animal Health Group PLC 24 January 2022
ECO Animal Health Group plc
(''ECO" or "the ECO Group") (AIM: EAH)
Investor Presentation
ECO Animal Health Group plc (AIM: EAH), a leader in the development,
registration and marketing of pharmaceutical products for global animal health
markets, is pleased to announce that Marc Loomes, CEO, Christopher Wilks, CFO,
and Hafid Benchaoui, Global Head of R&D, will be conducting a live
presentation following their Capital Markets Day to institutional investors at
9am.
The online presentation will take place on Wednesday 26th January at
2.30pm London time.
ECO started a programme of significant R&D investment in vaccines around
four years ago and has seen meaningful progress. This event will be an
opportunity for investors to hear insights from the management team and
further details of the potential commercial value that exists within the new
product development pipeline.
The presentation is open to all existing and potential shareholders and
registration is free. Questions can be submitted during the presentation and
will be addressed at the end.
To register for the online event, please go to:
https://www.equitydevelopment.co.uk/news-and-events/ecoanimalhealth-investorspresentation-26jan
(https://www.equitydevelopment.co.uk/news-and-events/ecoanimalhealth-investorspresentation-26jan)
A recording of the presentation will be available shortly after the event.
Contacts:
020 8447 8899
ECO Animal Health Group plc
Marc Loomes (CEO)
Chris Wilks (FD)
IFC Advisory 020 3934 6630
Graham Herring
Zach Cohen
Singer Capital Markets (Nominated Adviser & Joint Broker) 020 7496 3000
Mark Taylor
George Tzimas
Investec (Joint Broker) 020 7597 5970
Gary Clarence
Alex Penney
Carlo Spingardi
Peel Hunt LLP (Joint Broker) 020 7418 8900
Dr Christopher Golden
James Steel
Equity Developments 020 7065 2692
Hannah Crowe
Matt Evans
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and
commercialises products for livestock. Our business strategy is to generate
shareholder value by achieving the maximum sales potential from the existing
product portfolio whilst investing in Research and Development ("R&D") for
new products, particularly vaccines, and seeking to in-license new products.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAUAUVRUSUAUAR